Submit an Article
Navigate
Home
Editorial Board
Editorial Policies
Current Volume
Archive
Scientific Integrity
Publication Ethics Statements
Interviews with Outstanding Authors
Newsroom
Sponsored Conferences
Podcast
Contact
Special Collections
Submit an Article
Online ISSN: 1945-4589
Research Paper
|
Volume 11, Issue 6
|
pp. 1716–1732
Elevated FPR confers to radiochemoresistance and predicts clinical efficacy and outcome of metastatic colorectal cancer patients
Back to article
Figure 6
(6 of 6)
−
100%
+
Figure 6.
Diagram depicting the cause of survival difference between left- and right-sided mCRC and the optimal common treatment selection for the patients according to FPR.
